COVAX on the move
COVAX on the move
4 April 2022
Credit: UNICEF/UN0435055/Fadhel
Over the past year the Gavi COVAX AMC has been able to deliver 1.4 billion doses of life-saving jabs to 145 countries.
Over the past year, despite uncertain vaccine supply, unreliable supply chains, export controls and restrictions, COVAX AMC has been able to deliver 1.4 billion1 doses of life-saving jabs to 145 countries, reaching some of the poorest and most remote places on earth. IFFIm has supported this herculean humanitarian effort with US$ 975 million in cash disbursements allocated for the COVAX AMC’s 92 participating economies.
Successes in some of these countries demonstrate the COVAX AMC’s accomplishments. For example, Nepal has already vaccinated more than 75% of its population. And, in just five months, Vietnam went from the second lowest vaccine coverage in Southeast Asia to an exemplar – vaccinating 100% of its population, with 90% now fully vaccinated.2
Still, hundreds of millions of people, most in lower-income countries, remain unvaccinated and unprotected, and the virus is evolving: a major variant has been identified every four months, on average, since the pandemic was declared.
A key lesson learned during the pandemic is the need for upfront cash to procure large volumes of vaccines at sustainable prices. IFFIm’s capability to frontload funding has given Gavi reliable, standby cash, and that strengthens its negotiating hand. This helps procure vaccines that are affordable and sustainable, preventing the gulf between the vaccine haves and have-nots from widening.
To achieve that kind of security in 2022 and beyond, IFFIm funding will help build a global Pandemic Vaccine Pool to react immediately to unforeseen shocks and risks as the COVID-19 pandemic enters year three. The initiative will be funded by up to US$ 2.7 billion in commitments and is structured so it can be funded by direct cash contributions and attract pledges made through new contingent financing features.
For the latest on COVAX and COVID-19 visit Gavi.org and the COVID-19 vaccine market dashboard.
1 https://www.unicef.org/supply/covid-19-vaccine-market-dashboard
2 https://www.gavi.org/vaccineswork/vietnam-vaccinates-90-its-population-against-covid-19
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024